首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

彈性體輸液幫浦市場規模、佔有率和成長分析（按產品、應用、最終用途和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1898453

彈性體輸液幫浦市場規模、佔有率和成長分析（按產品、應用、最終用途和地區分類）—產業預測（2026-2033 年）

Elastomeric Infusion Pumps Market Size, Share, and Growth Analysis, By Product (Continuous Rate EIP, Variable Rate EIP), By Application (Pain Management, Antibiotic/Antiviral Therapy), By End Use, By Region -Industry Forecast 2026-2033

出版日期: 2025年12月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，彈性輸液幫浦市場規模將達到 7.3454 億美元，從 2025 年的 7.8816 億美元成長到 2033 年的 13.8488 億美元，在預測期（2026-2033 年）內複合年成長率為 7.3%。

彈性體輸液幫浦市場受到糖尿病、心血管疾病和癌症等慢性疾病日益普遍的顯著影響，這些疾病是全球主要的死亡原因。人們越來越重視有效的疾病管理，這推動了對彈性體幫浦等持續給藥系統的需求。推動該市場發展的關鍵因素之一是居家醫療解決方案需求的不斷成長。這些設備為那些希望在家接受治療的患者提供了便利性和易用性。此外，人口老化導致的長期照護需求也是推動這一趨勢的重要因素。為了促進市場成長，製造商正在不斷創新彈性體幫浦技術，以提高輸注精度、延長輸注時間並增強功能，從而在確保可靠性的同時，滿足不同患者和醫療保健專業人員的需求。

彈性體輸液幫浦市場促進因素

全球彈性體輸液幫浦市場的主要促進因素之一是慢性疾病的日益普遍，這些疾病需要先進且有效的治療方案。糖尿病、癌症和疼痛管理等疾病需要持續給藥，導致對可靠易用的輸液解決方案的需求激增。彈性體輸液幫浦具有許多優勢，包括易於使用、便於攜帶以及降低併發症風險，使其成為傳統方法的理想替代方案。此外，居家醫療和門診護理模式的不斷普及，以及輸液幫浦能夠實現持續給藥，也正在推動市場成長。

限制彈性體輸液幫浦市場的因素

全球彈性體輸液幫浦市場的主要限制因素之一是人們對藥物輸送系統的安全性和準確性日益成長的擔憂。醫療專業人員越來越警惕輸液幫浦可能出現的錯誤，例如藥物劑量計算錯誤或機械故障，這些都可能導致嚴重的患者併發症。醫療設備嚴格的監管要求進一步加劇了這種擔憂，迫使製造商投入大量資金進行研發以改善安全性能。因此，高成本和漫長的核准流程可能會阻礙新進者，並限制彈性體輸液幫浦領域的創新和擴張機會。

彈性體輸液幫浦市場趨勢

彈性體輸液幫浦市場正呈現出顯著的數位化醫療解決方案整合趨勢，旨在打造混合模式以提升患者照護。傳統彈性體輸液幫浦與遠端醫療平台和智慧型手機應用程式的融合，透過即時監測和輸液調整，顯著提高了治療的準確性和效率。這種整合不僅使醫護人員能夠遠端監測輸液過程，從而提升了護理標準，而且還能夠在必要時進行即時干預，從而增強了患者安全。因此，隨著人們對便利高效的醫療解決方案的需求日益成長，彈性體輸液幫浦在居家醫療領域也越來越受歡迎。

百特（美國）
費森尤斯卡比股份公司（德國）
B. Braun SE（德國）
Ambu A/S（丹麥）
NIPRO（日本）
泰爾茂株式會社（日本）
AVNS（美國）
維貢集團（法國）
史密斯Group Limited（英國）
ICU Medical, Inc.（美國）
Pajunk GmbH（德國）
宇榮醫療有限公司（韓國）
藍寶石醫療（以色列）
艾斯醫療有限公司（韓國）
伊坦醫療（以色列）
Zyno Medical（美國）
Epic Medical（新加坡）
日本尼普洛株式會社
大研醫療株式會社（日本）
Coopdech（日本）
Westmed公司（美國）
Flowonix Medical Inc.（美國）

簡介目錄

Product Code: SQMIG35A2679

Elastomeric Infusion Pumps Market size was valued at USD 734.54 Million in 2024 and is poised to grow from USD 788.16 Million in 2025 to USD 1384.88 Million by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).

The elastomeric infusion pumps market is significantly influenced by the rising prevalence of chronic diseases such as diabetes, cardiovascular issues, and cancer, which are major contributors to global mortality. This increased focus on effective disease management has led to a growing demand for continuous medication delivery systems like elastomeric pumps. A pivotal factor driving this market is the escalating need for home healthcare solutions, as these devices offer mobility and ease of use for patients preferring treatment in their homes. Furthermore, the aging population's need for long-term care supports this trend. To enhance market growth, manufacturers are innovating elastomeric pump technology to improve accuracy, extend infusion durations, and develop better functionalities, ensuring reliability while meeting diverse patient and healthcare professional requirements.

Top-down and bottom-up approaches were used to estimate and validate the size of the Elastomeric Infusion Pumps market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Elastomeric Infusion Pumps Market Segments Analysis

Global Elastomeric Infusion Pumps Market is segmented by Product, Application, End Use, and region. Based on Product, the market is segmented into Continuous Rate Elastomeric Infusion Pumps, and Variable Rate Elastomeric Infusion Pumps. Based on function, the market is segmented into Pain Management, Chemotherapy, Antibiotic/Antiviral Therapy, and Others. Based on End Use, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Elastomeric Infusion Pumps Market

One of the key market drivers for the global elastomeric infusion pumps market is the increasing prevalence of chronic diseases, necessitating advanced and effective treatment options. As conditions such as diabetes, cancer, and pain management require consistent medication delivery, the demand for reliable and user-friendly infusion solutions has surged. Elastomeric infusion pumps offer several advantages, including ease of use, portability, and reduced risk of complications, making them an attractive alternative to traditional methods. Furthermore, the ongoing shift towards home healthcare and outpatient treatment settings aligns with the infusion pump's ability to provide continuous drug delivery, propelling market growth.

Restraints in the Elastomeric Infusion Pumps Market

One significant market restraint for the global elastomeric infusion pumps market is the growing concern over safety and accuracy in medication delivery systems. Healthcare providers are increasingly wary of potential errors associated with infusion pumps, such as drug miscalculations or mechanical failures, which can lead to severe patient complications. This concern is further amplified by stringent regulatory requirements for medical devices, prompting manufacturers to invest heavily in research and development for improved safety features. Consequently, the high costs and lengthy approval processes may inhibit the entry of newer players, limiting innovation and expansion opportunities in the elastomeric infusion pump sector.

Market Trends of the Elastomeric Infusion Pumps Market

The Elastomeric Infusion Pumps market is witnessing a significant trend towards the integration of digital health solutions, creating a hybrid model that enhances patient care. The convergence of telemedicine platforms and smartphone applications with traditional elastomeric pumps offers improved therapy accuracy and efficiency through real-time monitoring and infusion adjustments. This integration not only elevates the standard of care by enabling healthcare professionals to remotely oversee infusion processes but also enhances patient safety, allowing for immediate intervention when necessary. As a result, elastomeric infusion pumps are gaining traction in home care environments, aligning with the increasing demand for accessible and efficient healthcare solutions.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Value Chain Analysis
Ecosystem of the Market
Case study Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Elastomeric Infusion Pumps Market by Product

Market Overview
Continuous Rate Elastomeric Infusion Pumps
Variable Rate Elastomeric Infusion Pumps

Elastomeric Infusion Pumps Market by Application

Market Overview
Pain Management
Chemotherapy
Antibiotic/Antiviral Therapy
Others

Elastomeric Infusion Pumps Market by End Use

Market Overview
Hospitals
Ambulatory Surgical Centers
Others

Elastomeric Infusion Pumps Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Baxter (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Kabi AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ambu A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NIPRO (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AVNS (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vygon Group (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smiths Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICU Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pajunk GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Woo Young Medical Co., Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sapphire Medical (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ace Medical Co., Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eitan Medical (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zyno Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Epic Medical (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Daiken Medical Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Coopdech (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Westmed, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Flowonix Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments